首页>
外国专利>
Use of pyruvate for retarding neutrophil infiltration and morphologic loss in ischemic bowel
Use of pyruvate for retarding neutrophil infiltration and morphologic loss in ischemic bowel
展开▼
机译:丙酮酸在缺血性肠中抑制中性粒细胞浸润和形态损失的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
Treating mammals having ischemic bowel with a therapeutic quantity of pyruvate enterally or parenterally will retard neutrophil infiltration and retain morphology during and following the bowel ischemia. The pyruvate is introduced into the patient enterally or parenterally during the bowel ischemia or the succeeding bowel reperfusion and, preferably, prior to the bowel ischemia. The pyruvate dosage is from 1% to 20% by weight of the patient's caloric intake.
展开▼